GMED — GLOBUS MEDICAL INC

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1237831 ·
Last close
$82.52
Market Cap
$9.35B
52W High
$97.39
52W Low
$74.50
ADV30
1,850,597
Next earnings
2026-08-06
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 759,854,000 525,788,000 161,977,000 124,302,000 5,439,555,000 560,950,000 707,243,000
Dec 2025 826,420,000 565,313,000 181,310,000 140,594,000 5,302,761,000 526,156,000 729,511,000
Sep 2025 769,048,000 516,515,000 135,008,000 118,966,000 5,095,640,000 371,769,000 696,815,000
Jun 2025 745,342,000 496,577,000 122,812,000 202,846,000 4,961,089,000 229,446,000 665,406,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$778,511,000
Investing CF
$-669,073,000
Financing CF
$-25,567,000
CapEx
$-177,937,000
Dividends Paid
Buybacks
$-110,000,000
EPS Diluted TTM
$4.30
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$1,512,259,000
Inventory
$772,602,000
Receivables
$735,439,000
ST Investments
$68,901,000
EBIT TTM
$601,107,000
Pretax Income TTM
$658,474,000
Interest Exp TTM
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,100,664,064
EBITDA
$945,059,008
Free Cash Flow
$341,059,616
Enterprise Value
$10,114,893,824
Total Cash
$629,851,008
Total Debt
$115,941,000
Shares Out
113,314,529
Trailing EPS
$4.28
Book Value
$34.88
ROE
13.3%
ROA
8.2%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,938,931,000 537,191,000 537,868,000 5,302,761,000 729,511,000 753,447,000
Dec 2024 2,519,355,000 219,387,000 102,984,000 5,251,750,000 1,074,417,000 520,638,000
Dec 2023 1,568,476,000 201,416,000 122,873,000 5,086,083,000 1,088,124,000 243,499,000
Dec 2022 1,022,843,000 236,251,000 190,169,000 2,076,126,000 229,753,000 178,468,000

TTM Snapshot

Revenues TTM
$1,142,900,000
NetIncome TTM
$150,942,000
OpCashFlow TTM
$0
Assets (Latest)
$5,251,750,000
Forward EPS
$5.15

Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)

max pain strike: $80.00 · spot: $82.52 · call volume: 397 · put volume: 7
Expected Move to 2026-07-17: ±$7.20 (8.73%) — implied range $75.32$89.72 · ATM straddle on $82.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
MASI MASIMO CORP $9.42B $179.95
BAX BAXTER INTERNATIONAL INC $10.34B $20.03
PODD INSULET CORP $11.06B $159.61
GKOS GLAUKOS Corp $7.42B $126.34
PEN Penumbra Inc $12.63B $321.06

News headlines (Yahoo Finance, 1h cache)

Here is Why Globus Medical (GMED) is One of the Most Profitable Growth Stocks to Buy
2026-06-09 23:22 · Yahoo
Should You Add Myriad Genetics Stock to Your Portfolio Right Now?
2026-06-09 14:01 · Yahoo
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
2026-06-09 14:01 · Yahoo
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
2026-06-09 12:55 · Yahoo
2 Reasons to Watch GMED and 1 to Stay Cautious
2026-06-08 18:13 · Yahoo
DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes
2026-06-08 17:29 · Yahoo
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
2026-06-08 15:52 · Yahoo
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
2026-06-08 15:49 · Yahoo
NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC
2026-06-08 15:48 · Yahoo
Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?
2026-06-08 13:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.